1.
Ueda Y, Ishii H, Kitano T, Shindo M, Miyazawa H, Ito K, Hirai K, Kaku Y, Mori H, Hoshino T, Ookawara S, Kakei M, Tabei K, Morishita Y. Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers. dti [Internet]. 2016 Sep. 11 [cited 2026 Jan. 8];10(1). Available from: https://journals.aboutscience.eu/index.php/dti/article/view/1422